Clinical Trial FAQ

Question 1

What Clinical Trials Are Currently Recruiting?

Accepted Answer

Thousands of clinical trials are actively recruiting participants right now across the United States and worldwide. These studies cover conditions ranging from cancer and heart disease to rare neurological disorders and skin conditions. Clinical trials listed on HelloStudys are verified as actively recruiting through ClinicalTrials.gov, each identified by a unique NCT number. You can browse by medical condition, location, or treatment type to find studies accepting new participants. Most recruiting trials need patients who meet specific eligibility criteria related to age, diagnosis, and treatment history. New studies open every week, so checking regularly increases your chances of finding a match. Our platform updates daily to ensure you see only current, open studies.

Question 2

How Do I Find Clinical Trials Near Me?

Accepted Answer

You can find clinical trials near you by searching on HelloStudys with your location and medical condition. Our platform matches you with recruiting studies at research sites in your area, including hospitals, universities, and specialty clinics. Start by entering your condition or keyword in our search bar, then filter results by city, state, or zip code. Each study listing shows all available site locations so you can pick the most convenient one. Many trials have dozens of sites across the country, including major cities like Dallas, Houston, Phoenix, and Salt Lake City. If no trials are nearby, some studies offer remote or hybrid participation options. You can also set up alerts to be notified when new trials open near your location.

Question 3

What Are the Requirements to Join a Clinical Trial?

Accepted Answer

Each clinical trial has its own eligibility criteria, but common requirements include age range, specific diagnosis, treatment history, and overall health status. These criteria ensure participant safety and valid study results. Eligibility criteria fall into two categories: inclusion criteria (what you must have) and exclusion criteria (what disqualifies you). Typical inclusion criteria include a confirmed diagnosis, being within a certain age range, and adequate organ function shown through lab tests. Exclusion criteria often include recent surgeries, certain medications, or other active medical conditions. Some trials are very specific, while others accept a broad range of participants. The best way to check your eligibility is to review the study details on our platform and express interest — a study coordinator will walk you through the screening process at no cost.

Question 4

Are Clinical Trials Free?

Accepted Answer

Yes, clinical trial participation is free for patients. The study sponsor covers the cost of the investigational treatment, required medical tests, and trial-related doctor visits. Some studies also offer compensation for your time and travel expenses. Pharmaceutical companies and research institutions fund clinical trials, so participants do not pay for the experimental treatment or procedures required by the study protocol. However, routine medical care not related to the trial may still be billed to your insurance. Many trials offer additional benefits like free health screenings, travel stipends, and parking reimbursement. Before enrolling, the study team will explain all costs and compensation through an informed consent process. If cost is a concern, ask the research coordinator about financial support options available for your specific trial.

Question 5

What Is an NCT Number and How Do I Find My Trial?

Accepted Answer

An NCT number is a unique identifier assigned to every clinical trial registered on ClinicalTrials.gov. It starts with "NCT" followed by an 8-digit number, like NCT12345678, and is the fastest way to look up a specific study. The National Library of Medicine assigns NCT numbers when researchers register their trials. This system ensures transparency and helps patients, doctors, and regulators track studies. You can search for any trial by its NCT number on HelloStudys or ClinicalTrials.gov to find details like eligibility criteria, locations, and study phase. If your doctor mentioned a trial, ask for the NCT number — it takes seconds to look up. Our platform shows recruiting status, site locations, and contact information for every NCT-registered study, making it easy to take the next step.

Question 6

Schizophrenia Clinical Trials: Latest Treatment Options 2026

Accepted Answer

Several new schizophrenia clinical trials are recruiting patients in 2026, testing next-generation antipsychotics, gene therapies, and novel mechanisms that target glutamate and muscarinic receptors rather than dopamine alone. Current schizophrenia research is moving beyond traditional dopamine-blocking drugs. Trials are testing muscarinic receptor agonists like KarXT, which showed reduced side effects in late-stage studies. Gene therapy approaches such as AMT-260 are exploring whether modifying specific neural pathways can provide longer-lasting relief. Other studies focus on cognitive symptoms that existing medications fail to address. Many trials are available at sites across major U.S. cities. If you or a loved one has treatment-resistant schizophrenia or wants access to emerging therapies, exploring clinical trials could open new options not yet available through standard care.

Question 7

What Is the AMT-260 Trial and Who Qualifies?

Accepted Answer

AMT-260 is an investigational gene therapy being studied in clinical trials for neurological conditions. The trial evaluates whether a single treatment can provide sustained improvement by targeting specific neural pathways at the genetic level. Gene therapy trials like AMT-260 aim to deliver corrective genetic material directly to affected cells, potentially offering long-term benefits from a single administration. Eligibility typically requires a confirmed diagnosis, being within a specified age range, adequate baseline health, and no recent use of certain medications. Participants usually undergo genetic screening as part of the enrollment process. These trials are conducted at specialized research centers with experience in gene therapy administration. Because gene therapy studies are highly sought after, early screening is recommended. Check HelloStudys for the latest AMT-260 recruiting status and site locations.

Question 8

Alternative Treatments for Schizophrenia Besides Medication

Accepted Answer

Beyond traditional antipsychotics, schizophrenia patients can explore clinical trials testing cognitive behavioral therapy for psychosis (CBTp), transcranial magnetic stimulation (TMS), gene therapies, and new drug classes with fewer side effects. Many patients seek alternatives due to side effects from conventional antipsychotics, including weight gain, drowsiness, and metabolic changes. Clinical trials offer access to experimental approaches not yet available commercially. Neurostimulation studies use targeted electrical or magnetic pulses to modulate brain activity. Digital therapeutics trials combine app-based interventions with clinical monitoring. Nutritional and microbiome studies explore the gut-brain connection in psychotic disorders. These alternatives are studied alongside standard care for safety. If current medications are not working well, a clinical trial may provide a supervised path to try something different while contributing to medical research.

Question 9

Breast Cancer Clinical Trials: New Treatment Options

Accepted Answer

Dozens of breast cancer clinical trials are recruiting now, testing targeted therapies, immunotherapy combinations, antibody-drug conjugates, and personalized treatment plans based on tumor genetics and biomarkers. Breast cancer research in 2026 focuses on precision medicine — matching treatments to your tumor's specific molecular profile. Antibody-drug conjugates (ADCs) like trastuzumab deruxtecan are being studied in expanded populations. Immunotherapy combinations with checkpoint inhibitors show promise for triple-negative breast cancer. CDK4/6 inhibitor trials explore new combinations for hormone-receptor-positive disease. Neoadjuvant studies test whether giving treatment before surgery improves outcomes. Trials are available for early-stage, locally advanced, and metastatic breast cancer at sites nationwide. Whether you are newly diagnosed or managing recurrent disease, clinical trials can offer access to cutting-edge treatments.

Question 10

What Should I Know Before Joining a Cancer Trial?

Accepted Answer

Before joining a cancer clinical trial, understand the study phase, potential risks and benefits, time commitment, treatment schedule, and how it compares to your current standard of care. Your oncologist can help evaluate if a trial is right for you. Key questions to ask include: What phase is the trial? Phase 1 trials test safety in small groups, while Phase 3 trials compare new treatments against the best current therapy. Understand the randomization process — you may receive the experimental treatment or a control. Ask about side effect monitoring and what happens if the treatment does not work. Review the informed consent document carefully; it details risks, procedures, and your rights. Consider the logistics: visit frequency, travel requirements, and impact on daily life. Many cancer centers have patient navigators who can explain trial options. Clinical trials provide close medical monitoring and may offer treatments years before they become widely available.

Question 11

Bladder Cancer Treatment Trials Near Me

Accepted Answer

Active bladder cancer clinical trials are recruiting at hospitals and cancer centers across the United States. Current studies are testing immunotherapy, targeted therapies, gene therapy, and bladder-preserving treatment approaches. Bladder cancer research has advanced significantly with immunotherapy. Checkpoint inhibitors like pembrolizumab and nivolumab are being tested in new combinations and earlier disease stages. Antibody-drug conjugates such as enfortumab vedotin are studied in combination regimens. For non-muscle-invasive bladder cancer, novel intravesical therapies aim to replace or enhance BCG treatment. Bladder-preserving approaches using combined chemoradiation are being refined through ongoing trials. Trials are available at major cancer centers and community oncology practices. Search by your city or zip code on HelloStudys to find bladder cancer trials accepting patients near you.

Question 12

How Effective Are New Leukemia Treatments?

Accepted Answer

New leukemia treatments in clinical trials are showing promising results. CAR-T cell therapies have achieved complete remission rates above 80% in certain types of acute leukemia, and targeted therapies are extending survival for chronic leukemia patients. Acute myeloid leukemia (AML) trials are testing combinations of targeted agents like venetoclax with hypomethylating agents, showing improved response rates in older adults. For acute lymphoblastic leukemia (ALL), bispecific antibodies and CAR-T cell therapy trials report high complete remission rates. Chronic lymphocytic leukemia (CLL) research focuses on BTK inhibitors and combination regimens that aim for deeper, longer-lasting responses. Minimal residual disease (MRD) testing in trials helps doctors determine if cancer cells are truly eliminated. These advances mean more treatment options than ever before, many accessible through clinical trials at specialized centers.

Question 13

Atopic Dermatitis: New Clinical Trial Treatments

Accepted Answer

New atopic dermatitis clinical trials are testing JAK inhibitors, IL-13 and IL-31 antibodies, topical PDE4 inhibitors, and microbiome-based therapies that go beyond traditional steroids to target the root causes of eczema flares. Atopic dermatitis research has expanded rapidly with biologic and small-molecule therapies. Dupilumab set the standard, and now trials test next-generation biologics targeting IL-13, IL-31 (itch-specific), and OX40 pathways. Oral JAK inhibitors like abrocitinib and upadacitinib are studied in long-term extension trials. Topical treatments including tapinarof and roflumilast cream offer steroid-free options. Microbiome transplant studies explore whether restoring healthy skin bacteria can reduce flares. Trials are available for mild, moderate, and severe atopic dermatitis in both adults and children. If over-the-counter treatments and prescriptions have not controlled your eczema, a clinical trial may provide relief.

Question 14

What's the Difference Between Phase 1, 2, and 3 Trials?

Accepted Answer

Phase 1 trials test safety and dosing in a small group (20-80 people). Phase 2 trials evaluate effectiveness and side effects in a larger group (100-300). Phase 3 trials confirm results in thousands of participants and compare the treatment to existing standard care. Before any human testing, treatments go through preclinical research in labs. Phase 1 is the first step in humans, focusing on finding the right dose and identifying side effects. If safe, Phase 2 expands to patients with the target condition to measure whether the treatment actually works. Phase 3 involves large-scale trials at multiple sites, often randomized and blinded, providing the evidence needed for FDA approval. Some trials combine phases (Phase 1/2 or Phase 2/3) to accelerate development. Later-phase trials generally offer more data on effectiveness but may have stricter eligibility. Understanding the phase helps you weigh the potential risks and benefits before enrolling.

Question 15

How Long Do Clinical Trials Take?

Accepted Answer

Clinical trial duration varies widely. Phase 1 trials typically last a few months, Phase 2 trials run 6 months to 2 years, and Phase 3 trials can take 1 to 4 years. Your individual participation time depends on the study protocol and treatment schedule. The total length of a trial differs from how long you personally participate. Some studies require only a single treatment visit with follow-up calls, while others involve weekly visits for a year or more. Cancer treatment trials often run 6 to 12 months of active treatment followed by years of monitoring. Vaccine trials may need just a few visits over several months. Before enrolling, the study team will provide a detailed schedule showing visit frequency, procedures at each visit, and total expected duration. Many patients find that trial visits replace some routine medical appointments, reducing the net time commitment. Ask the research coordinator for a calendar during screening.

Question 16

Is It Safe to Participate in Clinical Trials?

Accepted Answer

Clinical trials are carefully regulated to protect participant safety. Every trial must be approved by an Institutional Review Board (IRB) and follow strict FDA guidelines. You receive close medical monitoring throughout the study and can withdraw at any time. Safety is the top priority in clinical research. Before a trial begins, an IRB — an independent committee of doctors, researchers, and community members — reviews the study plan to ensure risks are minimized. During the trial, a Data Safety Monitoring Board watches for unexpected side effects and can stop the study if concerns arise. All potential risks are explained in the informed consent document before you agree to participate. Participants often receive more frequent check-ups and lab work than in routine care. Serious side effects are rare and closely tracked. If you experience any problems, the research team is required to provide appropriate medical care.

Question 17

What Happens During a Clinical Trial Visit?

Accepted Answer

During a clinical trial visit, you typically check in with the research team, undergo health assessments (vital signs, blood work, imaging), receive your study treatment, and report how you are feeling. Visits are scheduled at regular intervals outlined in the study protocol. Your first visit is usually a screening appointment where the team confirms your eligibility through medical history review, physical exams, and lab tests. If you qualify, subsequent visits follow a set schedule. Treatment visits may involve receiving medication, an infusion, or a procedure. The team will check vital signs, draw blood for safety labs, and ask about side effects using standardized questionnaires. Some visits include imaging scans or specialized tests. Each visit typically lasts 1 to 4 hours depending on the procedures required. Between visits, you may complete symptom diaries or use an app to report your health. The research team is available between visits if you have questions or concerns.

Question 18

Can I Withdraw From a Clinical Trial?

Accepted Answer

Yes, you can withdraw from a clinical trial at any time, for any reason, without penalty. Your decision to leave will not affect your regular medical care or your relationship with your healthcare provider. Voluntary participation is a cornerstone of clinical research ethics. The informed consent process makes it clear that you are never obligated to continue. If you decide to withdraw, simply notify your research coordinator. They may ask about your reasons to improve future studies, but you are not required to explain. The research team will advise you on any safety steps needed when stopping treatment, such as tapering medication rather than stopping suddenly. Any data collected during your participation may still be used in the study analysis unless you request otherwise where legally permitted. Your medical records from the trial will be shared with your regular doctor to ensure continuity of care.

Question 19

How Are Clinical Trial Participants Protected?

Accepted Answer

Clinical trial participants are protected by multiple layers of oversight including IRB review, FDA regulations, informed consent requirements, Data Safety Monitoring Boards, and the ethical principles of the Declaration of Helsinki and the Belmont Report. The U.S. federal government requires every clinical trial to be reviewed and approved by an Institutional Review Board before enrolling any participants. The IRB evaluates the study design, risk-benefit ratio, and informed consent process. During the study, a Data Safety Monitoring Board (DSMB) independently reviews safety data at regular intervals. The FDA can inspect trial sites and audit data at any time. Informed consent ensures you understand all risks, benefits, alternatives, and your right to withdraw. HIPAA regulations protect your medical information. If an unexpected serious adverse event occurs, it must be reported to the IRB and FDA within strict timelines. These protections work together to prioritize your safety above all else.

Question 20

What Are Common Side Effects in Clinical Trials?

Accepted Answer

Side effects in clinical trials vary by treatment type but commonly include fatigue, nausea, headache, and injection site reactions. All known and potential side effects are disclosed in the informed consent form before you enroll, and the research team monitors you closely throughout. Every medication — approved or experimental — can cause side effects. In clinical trials, the research team tracks all adverse events, from mild discomfort to serious reactions. Common side effects for drug trials include gastrointestinal issues, fatigue, skin reactions, and changes in blood counts detected through regular lab work. The informed consent document lists all side effects seen in earlier study phases. The team will explain which effects are expected versus which require immediate reporting. If you experience bothersome side effects, the research team can adjust your dose, provide supportive care, or discontinue treatment if needed. Reporting side effects helps researchers improve the treatment for future patients and is a valuable part of the trial process.